Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delmis E Hernandez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Central Science|March 4, 2020
Quorum Sensing Autoinducer-3 Finally Yields to Structural ElucidationDelmis E Hernandez, Herman O Sintim
Chemical Communications (Cambridge, England)|September 30, 2024
Orally bioavailable STING antagonist synthesized <i>via</i> multi-component Povarov-Doebner type reactionKofi B Owusu, Jyotrimayee Samal, Delmis E Hernandez, et al.
Chemical Communications (Cambridge, England)|April 10, 2018
Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitorClement Opoku-Temeng, Neetu Dayal, Delmis E Hernandez, et al.
Future Medicinal Chemistry|February 14, 2018
Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell linesNeetu Dayal, Clement Opoku-Temeng, Delmis E Hernandez, et al.
Psychopharmacology|July 2, 2026
Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in miceJawaun Harris, Dana R Chambers, Delmis E Hernandez, et al.
European Journal of Medicinal Chemistry|November 4, 2025
3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemiaNeetu Dayal, Eva Řezníčková, Delmis E Hernandez, et al.
Journal of Medicinal Chemistry|July 21, 2021
3<i>H</i>-Pyrazolo[4,3-<i>f</i>]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In VivoNeetu Dayal, Eva Řezníčková, Delmis E Hernandez, et al.
ACS Chemical Neuroscience|May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico StudyDelmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Central Science|March 4, 2020
Quorum Sensing Autoinducer-3 Finally Yields to Structural ElucidationDelmis E Hernandez, Herman O Sintim
Chemical Communications (Cambridge, England)|September 30, 2024
Orally bioavailable STING antagonist synthesized <i>via</i> multi-component Povarov-Doebner type reactionKofi B Owusu, Jyotrimayee Samal, Delmis E Hernandez, et al.
Chemical Communications (Cambridge, England)|April 10, 2018
Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitorClement Opoku-Temeng, Neetu Dayal, Delmis E Hernandez, et al.
Future Medicinal Chemistry|February 14, 2018
Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell linesNeetu Dayal, Clement Opoku-Temeng, Delmis E Hernandez, et al.
Psychopharmacology|July 2, 2026
Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in miceJawaun Harris, Dana R Chambers, Delmis E Hernandez, et al.
European Journal of Medicinal Chemistry|November 4, 2025
3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemiaNeetu Dayal, Eva Řezníčková, Delmis E Hernandez, et al.
Journal of Medicinal Chemistry|July 21, 2021
3<i>H</i>-Pyrazolo[4,3-<i>f</i>]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In VivoNeetu Dayal, Eva Řezníčková, Delmis E Hernandez, et al.
ACS Chemical Neuroscience|May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico StudyDelmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Pageof 1